A Blank Rome team represented an affiliate of Balmoral Funds LLC (“Balmoral”), a Los Angeles-based private equity firm founded in 2005, in its acquisition of Wilbur-Ellis Nutrition, LLC (the “Company”), a leading provider of animal nutrition products and services for the pet, aquaculture, and livestock industries, serving as a critical supplier across the value chain. Blank Rome also represented Balmoral in connection with the financing for the transaction. The Company will operate under the name Rangen, a historic brand that many of its customers are already familiar with. The transaction closed on August 26, 2025.
For more information about the transaction, please read the press release: An Affiliate of Balmoral Funds LLC Acquires Wilbur-Ellis Nutrition, LLC.
The Blank Rome team on the mergers and acquisitions side was led by Kipp B. Cohen and John A. Meehan, with significant support from Joseph T. Gulant, Cory G. Jacobs, Jeffrey M. Rosenfeld, Jason E. Reisman, Michael A. Kadlec, Margaret Anne Hill, Alex C. Nisenbaum, Lisa Casey Spaniel, Anthony Rapa, Shane A. Pennington, Yelena M. Barychev, Adam P. Haft, Rachel M. Smaler, Brian P. O'Neil, Sarah E. Thorpe, Jacob M. Brownstein, Carmen F. Francella III, Stephen M. Pennartz, Christopher A. Kimura, Samar Aryani-Sabet, Samarth Barot, Shane M. Hannon, Stephen C. Zumbrun, Melissa A. Griest, and Ivy Shapiro. The Blank Rome team on the finance side was led by Shlomo Troodler and Adam R. Sansweet, with significant support from Ikhwan A. Rafeek, Narbeh Grigorian, and Mya J. K. Roberts.
